Monthly Prescribing Reference

FDA to Review Lotion Formulation of Tazarotene for Acne Treatment

A Prescription Drug User Fee Act (PDUFA) target date of December 22, 2019 has been set for this tazarotene lotion application. The Food and Drug Administration (FDA) has accepted for review the New ...
Nasdaq

Bausch Health Announces U.S. Launch of DUOBRII(TM) (halobetasol propionate and tazarotene) Lotion 0.01%/0.045% for Plaque Psoriasis in Adults

LAVAL, Quebec, June 25, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care ...
Medscape

FDA Approves Adapalene Lotion to Treat Acne

March 23, 2010 — The US Food and Drug Administration (FDA) has approved the first lotion formulation of adapalene (Differin 0.1%, Galderma Laboratories, LP) for the topical treatment of acne in ...
Business Insider

Bausch Health's BRYHALI™(halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults

In Clinical Trials, BRYHALI Lotion Demonstrated Significant Treatment Success Over Vehicle as Early as Week Two, Which Continued Through Week 12 (Four Weeks Post Treatment) 1 New Corticosteroid Lotion ...
Medindia

Galderma Received FDA Approval of Differin(R) (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation

FORT WORTH, Texas, March 22 /PRNewswire/ -- Galderma Laboratories, L.P. today announced the U.S. Food and Drug Administration (FDA) approval of Differin® (adapalene) Lotion, 0.1%, the first-ever ...
Bustle

CeraVe Moisturizing Cream Vs. Lotion — Here’s The Lowdown

CeraVe Moisturizing Cream, and its lighter-weight counterpart, CeraVe Daily Moisturizing Lotion, are both cult classics in their own right. But what sets these two moisturizers apart? To start with ...